Viewing Study NCT01988493


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2026-02-25 @ 4:49 PM
Study NCT ID: NCT01988493
Status: COMPLETED
Last Update Posted: 2022-08-24
First Post: 2013-11-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Participants With Hepatocellular Carcinoma
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Hepatocellular View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Carcinoma, Hepatocellular View
None MSC2156119J View
None Sorafenib View
None Recommended Phase 2 dose View